Recursion Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $653.7M
Liabilities Breakdown FY2023
Total Liabilities: $190.3M
Asset Breakdown
Total Assets: $653.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $391.6M | 59.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $86.5M | 13.2% |
| Goodwill | $52.1M | 8.0% |
| Intangible Assets | $36.4M | 5.6% |
| Other Assets | $87.1M | 13.3% |
Liabilities Breakdown
Total Liabilities: $190.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.0M | 2.1% |
| Long-Term Debt | $1.1M | 0.6% |
| Other Liabilities | $185.2M | 97.3% |